RecruitingPhase 3NCT03933631
Pilocarpine Use After Kahook Goniotomy
A Prospective Randomized Control Trial of Pilocarpine Use After Combined Cataract/Kahook Dual Blade Surgery
Sponsor
Montefiore Medical Center
Enrollment
142 participants
Start Date
May 1, 2019
Study Type
INTERVENTIONAL
Conditions
Summary
The goal of this study is to determine whether using pilocarpine provides added benefit to the success of combined cataract + Kahook Dual Blade (KDB) surgery.
Eligibility
Min Age: 30 YearsMax Age: 100 Years
Inclusion Criteria1
- Patients with ocular hypertension or open angle glaucoma undergoing combined cataract surgery with KDB in a single surgical center at Montefiore Medical Center with a single provider
Exclusion Criteria1
- Patients with previous history of eye surgeries (including laser procedures)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGPilocarpine
pilocarpine hydrochloride ophthalmic solution 2% (20 mg/mL)
DRUGPrednisolone
Prednisolone acetate ophthalmic suspension 1%
DRUGOfloxacin
Ofloxacin Drops
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03933631
Related Trials
Glaucoma Related Quality of Life
NCT075100871 location
Efficacy and Safety of the ELIOS Laser in Combined Cataract and Glaucoma Surgery
NCT067601691 location
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
NCT0716890214 locations
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
NCT074958521 location
A Trial of Hydrus Microstent Versus Goniotomy
NCT062894911 location